Desktop Health™ specializes in advanced 3D printing technologies that have been refined over more than two decades, focusing on enhancing patient care in dental and medical fields. Their high-accuracy 3D printers utilize premium biocompatible materials, ensuring reliable and regulatory-approved solutions. The company boasts an extensive portfolio of over 950 patents and more than 1,400 published research papers, underscoring its commitment to innovation in biofabrication and 3D printing applications. Their technology supports a variety of print modalities and is trusted by leading institutions in tissue engineering, with applications ranging from bone and cartilage regeneration to soft tissue fabrication and organ printing.

The materials developed by Desktop Health include a diverse range of biocompatible options such as photopolymers, ceramics, hydrogels, and thermoplastics, each tailored for specific medical and dental applications. Their Flexcera resin, for instance, is an FDA-cleared nanoceramic polymer designed for creating functional and aesthetically pleasing dental prosthetics. Additionally, their hydrogels and thermoplastics are engineered to support cell-friendly environments, making them suitable for regenerative medicine applications. This comprehensive approach to 3D printing technology positions Desktop Health as a leader in personalized patient care, leveraging cutting-edge materials and processes to meet the evolving needs of healthcare professionals.

United States

Desktop Health develops, manufactures, and markets a suite of leading 3D printing and biofabrication solutions. One of products that the company is investigating are 3D printed eardrums.

Desktop Health

Company Details